Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
15-valent pneumococcal conjugate vaccine coadministered with DTaP vaccine in infants
CTR20211737Phase 3Completed
- Sponsor
- Zhifei Biological
- Start
- Jul 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of 15-valent pneumococcal conjugate vaccine in invasive pneumococcal disease (IPD), sponsored by Zhifei Biological. Started Jul 2021; status: completed.
02
Drugs
15-valent pneumococcal conjugate vaccine
03
Conditions
invasive pneumococcal disease (IPD)
Beyond the preview
Go deeper on CTR20211737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211737.